JNCE logo

Jounce Therapeutics (JNCE) Current Assets

Annual Current Assets

$197.23 M
+$6.40 M+3.36%

December 31, 2022


Summary


Performance

JNCE Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherJNCEbalance sheetmetrics:

Quarterly Current Assets

$197.23 M
+$57.30 M+40.95%

December 31, 2022


Summary


Performance

JNCE Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherJNCEbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

JNCE Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3.4%+3.4%
3 y3 years+13.6%+13.6%
5 y5 years-22.8%-22.8%

JNCE Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-3.2%at high-29.1%
5 y5-year-6.7%-11.9%-26.1%-45.5%
alltimeall time-22.8%-98.5%-29.4%-76.8%

Jounce Therapeutics Current Assets History

DateAnnualQuarterly
Dec 2022
$15.32 M(-75.2%)
$197.23 M(+40.9%)
Sep 2022
-
$139.93 M(-11.1%)
Jun 2022
-
$157.35 M(-4.5%)
Mar 2022
-
$164.84 M(-13.6%)
Dec 2021
$61.87 M(+88.4%)
$190.83 M(-16.8%)
Sep 2021
-
$229.25 M(-10.8%)
Jun 2021
-
$257.12 M(-3.7%)
Mar 2021
-
$267.01 M(+26.3%)
Dec 2020
$32.84 M(+2.1%)
$211.39 M(+96.7%)
Sep 2020
-
$107.46 M(-18.2%)
Jun 2020
-
$131.31 M(-13.8%)
Mar 2020
-
$152.36 M(-12.3%)
Dec 2019
$32.19 M
$173.70 M(-4.1%)
Sep 2019
-
$181.05 M(+15.1%)
DateAnnualQuarterly
Jun 2019
-
$157.35 M(-7.4%)
Mar 2019
-
$169.88 M(-11.6%)
Dec 2018
$22.24 M(-45.8%)
$192.21 M(-10.3%)
Sep 2018
-
$214.37 M(-8.9%)
Jun 2018
-
$235.33 M(-8.6%)
Mar 2018
-
$257.61 M(+0.8%)
Dec 2017
$41.06 M(-65.6%)
$255.60 M(-1.6%)
Sep 2017
-
$259.82 M(-7.0%)
Jun 2017
-
$279.32 M(+4.8%)
Mar 2017
-
$266.42 M(+75.5%)
Dec 2016
$119.53 M(+1545.4%)
$151.79 M(-10.7%)
Sep 2016
-
$170.01 M(+271.9%)
Dec 2015
$7.26 M(+56.2%)
$45.71 M
Dec 2014
$4.65 M
-

FAQ

  • What is Jounce Therapeutics annual total current assets?
  • What is the all time high annual current assets for Jounce Therapeutics?
  • What is Jounce Therapeutics annual current assets year-on-year change?
  • What is Jounce Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Jounce Therapeutics?
  • What is Jounce Therapeutics quarterly current assets year-on-year change?

What is Jounce Therapeutics annual total current assets?

The current annual current assets of JNCE is $197.23 M

What is the all time high annual current assets for Jounce Therapeutics?

Jounce Therapeutics all-time high annual total current assets is $255.60 M

What is Jounce Therapeutics annual current assets year-on-year change?

Over the past year, JNCE annual total current assets has changed by +$6.40 M (+3.36%)

What is Jounce Therapeutics quarterly total current assets?

The current quarterly current assets of JNCE is $197.23 M

What is the all time high quarterly current assets for Jounce Therapeutics?

Jounce Therapeutics all-time high quarterly total current assets is $279.32 M

What is Jounce Therapeutics quarterly current assets year-on-year change?

Over the past year, JNCE quarterly total current assets has changed by +$6.40 M (+3.36%)